Document is current

Any future updates will be listed below

Correction to: Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents

Crossref DOI link: https://doi.org/10.1007/s40259-020-00410-5

Published Online: 2020-02-26

Published Print: 2020-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark